Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,000 | 6,201,000 | 5,825,000 | 3,239,000 | 1,722,000 |
| Depreciation Amortization | 525,000 | 2,050,000 | 1,515,000 | 992,000 | 473,000 |
| Income taxes - deferred | -651,000 | -116,000 | 243,000 | 3,000 | 71,000 |
| Accounts receivable | 699,000 | 313,000 | 272,000 | 694,000 | 975,000 |
| Accounts payable and accrued liabilities | -91,000 | -118,000 | -242,000 | -222,000 | -253,000 |
| Other Working Capital | -1,162,000 | 489,000 | -1,325,000 | -872,000 | -409,000 |
| Other Operating Activity | 2,508,000 | 2,565,000 | 1,891,000 | 1,092,000 | 31,000 |
| Operating Cash Flow | $1,840,000 | $11,384,000 | $8,179,000 | $4,926,000 | $2,610,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,000 | -607,000 | -577,000 | -577,000 | -252,000 |
| PPE Investments | -247,000 | -579,000 | -423,000 | -284,000 | -165,000 |
| Net Acquisitions | -807,000 | -1,584,000 | -1,540,000 | -1,457,000 | -1,255,000 |
| Purchase Of Investment | -28,000 | -380,000 | -332,000 | -301,000 | -279,000 |
| Other Investing Activity | 0 | 19,000 | 19,000 | 0 | -91,000 |
| Investing Cash Flow | $-1,070,000 | $-3,131,000 | $-2,853,000 | $-2,619,000 | $-2,042,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -500,000 | -4,750,000 | -3,750,000 | -1,250,000 | -1,250,000 |
| Common Stock Issued | 94,000 | 169,000 | 157,000 | 100,000 | 88,000 |
| Common Stock Repurchased | -352,000 | -546,000 | -497,000 | -352,000 | -309,000 |
| Dividend Paid | -945,000 | -3,605,000 | -2,711,000 | -1,811,000 | -917,000 |
| Other Financing Activity | -91,000 | -145,000 | -134,000 | -95,000 | -89,000 |
| Financing Cash Flow | $-1,794,000 | $-8,877,000 | $-6,935,000 | $-3,408,000 | $-2,477,000 |
| Exchange Rate Effect | -18,000 | -35,000 | -26,000 | -3,000 | -23,000 |
| Beginning Cash Position | 5,338,000 | 5,997,000 | 5,997,000 | 5,997,000 | 5,997,000 |
| End Cash Position | 4,296,000 | 5,338,000 | 4,362,000 | 4,893,000 | 4,065,000 |
| Net Cash Flow | $-1,042,000 | $-659,000 | $-1,635,000 | $-1,104,000 | $-1,932,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,840,000 | 11,384,000 | 8,179,000 | 4,926,000 | 2,610,000 |
| Capital Expenditure | -247,000 | -579,000 | -423,000 | -284,000 | -165,000 |
| Free Cash Flow | 1,593,000 | 10,805,000 | 7,756,000 | 4,642,000 | 2,445,000 |